---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-032626"
form_type: "8-K"
ticker: "CVRX"
cik: "0001235912"
company_name: "CVRx, Inc."
filed_at: "2025-04-07T23:59:59+00:00"
generated_at: "2026-05-23T19:27:10.183284+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CVRx preliminary Q1 revenue $12.3M (+15% YoY) but below expectations; cites seasonality, new rep ramp

## Summary
- Preliminary Q1 2025 revenue ~$12.3M, up 15% YoY from $10.8M.
- U.S. revenue ~$11.2M; European revenue ~$1.1M.
- Active U.S. implant centers 227 (up from 223 at year-end); sales territories reduced to 45.
- Cash and equivalents $102.7M; issued 543,462 shares for $9.5M under ATM in Q1.
- CEO noted revenue fell short due to new sales reps developing and Q1 seasonality; full results due May 8.

## SEC filing metadata
- accession: 0001104659-25-032626
- form_type: 8-K
- ticker: CVRX
- cik: 0001235912
- company_name: CVRx, Inc.
- filed_at: 2025-04-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1235912/000110465925032626/0001104659-25-032626-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1235912/000110465925032626/tm2511651d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-032626
- JSON: https://secwatch.observer/filing/0001104659-25-032626.json
- Plain text: https://secwatch.observer/filing/0001104659-25-032626.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.